investorscraft@gmail.com

Intrinsic ValueShanghai W-Ibeda High Tech.Group Co.,Ltd. (688071.SS)

Previous Close$39.45
Intrinsic Value
Upside potential
Previous Close
$39.45

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Shanghai W-Ibeda High Tech. Group Co., Ltd. operates as a specialized manufacturer of automotive powertrain test bench systems within China's auto parts sector. The company's core revenue model is driven by the development, production, and sale of sophisticated testing equipment for both traditional internal combustion engines and new energy vehicle (NEV) powertrains, supplemented by technical services and the operation of dedicated test centers. Its comprehensive product portfolio includes engine NVH, performance, and reliability test benches, alongside specialized testers for transmissions, electrical systems, and HEV/EV components, catering to the rigorous quality control and R&D needs of automotive manufacturers. Operating from its Shanghai base since 1998, the company has established a niche market position by focusing on high-tech, capital-intensive testing solutions that are critical for vehicle development, positioning it as a domestic supplier in China's vast and evolving automotive industry, with additional revenue from exports.

Revenue Profitability And Efficiency

The company reported revenue of CNY 423.4 million for the period. However, it experienced a net loss of CNY -46.7 million, resulting in negative diluted EPS of -0.55 CNY. Operating cash flow was positive at CNY 46.4 million, but this was significantly overshadowed by substantial capital expenditures of CNY -162.2 million, indicating heavy investment in its operational capacity.

Earnings Power And Capital Efficiency

Current earnings power is challenged, as evidenced by the net loss. The significant capital expenditure outlay, which far exceeded operating cash flow, suggests the company is in an investment-intensive phase, potentially aimed at expanding its test bench manufacturing capabilities or developing new products for the evolving automotive market, particularly in new energy vehicles.

Balance Sheet And Financial Health

The balance sheet shows a cash position of CNY 95.0 million against a considerably higher total debt of CNY 790.8 million. This high debt-to-cash ratio indicates a leveraged financial structure, which could pressure liquidity and increase financial risk, especially in a period of operational losses and high capital investment requirements.

Growth Trends And Dividend Policy

The substantial capital expenditures signal a strategy focused on growth and capacity expansion rather than immediate shareholder returns. Reflecting this focus, the company paid no dividend during the period. Future growth is likely tied to the adoption of its testing solutions by automakers, particularly in the expanding Chinese NEV sector.

Valuation And Market Expectations

With a market capitalization of approximately CNY 3.32 billion, the market valuation appears to be factoring in future growth potential from its investments and positioning in the automotive testing niche. The low beta of 0.484 suggests the stock is perceived as less volatile than the broader market, possibly due to its specialized, B2B nature.

Strategic Advantages And Outlook

The company's strategic advantage lies in its specialized expertise and product range for critical automotive testing, a necessary function for manufacturers. The outlook depends on its ability to convert heavy investments into profitable revenue growth, manage its debt load, and successfully capitalize on the ongoing transition to new energy vehicles within its core market.

Sources

Company DescriptionProvided Financial Data

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount